World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
116
Citations
63344
World Ranking
4293
National Ranking
164

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Ferdinand C. Breedveld is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on the field of Medicine, with a significant emphasis on Rheumatology. Other subfields of study include Hematology, Genetics, and Pathology and Forensic Medicine.

The main topics of their work cover a range of areas within medical research, including:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Spondyloarthritis Studies and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment

Breedveld has published in notable venues related to their fields of study. Frequent publication venues are:

  • Annals of the Rheumatic Diseases
  • The Open Rheumatology Journal

Recent papers authored or co-authored by Breedveld include:

  • "Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023" (2023), published in Annals of the Rheumatic Diseases
  • "Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status" (2021), published in The Open Rheumatology Journal

Breedveld collaborates with several frequent co-authors in their research work. These include:

  • Kevin Winthrop
  • Philip J. Mease
  • Andreas Kerschbaumer
  • Reinhard Voll
  • Josef S Smolen

Their research contributions span clinical and translational aspects of rheumatology and related autoimmune diseases, focusing on disease mechanisms and therapeutic strategies. The involvement in studies related to rheumatoid arthritis and inflammatory disorders is notable in their publication record.

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

    G.A. Schellekens;H.K.A. Visser;B.A.W. de Jong;F.H.J. van den Hoogen

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

    Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • A simplified disease activity index for rheumatoid arthritis for use in clinical practice

    J.S. Smolen;F.C. Breedveld;M.H. Schiff;J.R. Kalden

  • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

    Paul Emery;Ferdinand C Breedveld;Stephen Hall;Patrick Durez

  • How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

    Henk Visser;Saskia le Cessie;Koen Vos;Ferdinand C. Breedveld

  • Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

    F.A. van Gaalen;S.P. Linn-Rasker;W.J.W. van Venrooij;B.A. de Jong

  • Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

    Leroy R Lard;Henk Visser;Irene Speyer;Irene E vander Horst-Bruinsma

  • Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

    Tom W. J. Huizinga;Christopher I. Amos;Annette H. M. van der Helm-van Mil;Wei Chen

  • The Safety and Efficacy of a JAK Inhibitor in Patients With Active Rheumatoid Arthritis Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 Versus Placebo

    Joel M. Kremer;Bradley J. Bloom;Ferdinand C. Breedveld;John H. Coombs

  • Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

    Peter Charles;Michael J. Elliott;Diana Davis;Alison Potter

  • Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

    P. P. Tak;T. J. M. Smeets;M. R. Daha;P. M. Kluin

  • Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

    Annette H M van der Helm-van Mil;Kirsten N Verpoort;Ferdinand C Breedveld;René E M Toes

  • A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis

    P Emery;F C Breedveld;E M Lemmel;J P Kaltwasser

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

Frequent Co-Authors

Paul Emery
Paul Emery University of Leeds
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Tom W. J. Huizinga
Tom W. J. Huizinga Leiden University Medical Center
Ben A. C. Dijkmans
Ben A. C. Dijkmans Amsterdam UMC
Maxime Dougados
Maxime Dougados Hôpital Cochin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Tore K. Kvien
Tore K. Kvien University of Oslo
Margreet Kloppenburg
Margreet Kloppenburg Leiden University Medical Center
Robert Landewé
Robert Landewé University of Amsterdam
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a career in medicine but want flexibility, various online programs can help you advance without disrupting your current commitments. For those aiming for healthcare leadership, cahme accredited online mha programs offer a rigorous curriculum tailored for future administrators, ensuring high-quality standards recognized in the industry.

Registered Nurses looking to elevate their qualifications can benefit from convenient rn to bsn online no clinicals accredited programs—ideal for those wanting to upgrade without additional clinical requirements. For nurses striving for advanced practice or leadership roles, accelerated options like short dnp programs can quickly lead to a Doctor of Nursing Practice degree, helping you fast-track your expertise.

Flexibility remains a key advantage, especially with diverse dnp online programs now available for a variety of learning needs and backgrounds. Each pathway provides opportunities to shape your medical career with accredited, reputable education at your own pace.

Best Scientists Citing Ferdinand C. Breedveld

Trending Scientists

Recently Published Articles